Microparticles (MPs) resulting from vesiculation of platelets and other blood cells have been
extensively documented in vitro and have been found in increased numbers in several …

The development of vasculopathies in diabetes involves multifactorial processes including
pathological activation of vascular cells. Release of microparticles by activated cells has been …

The antiphospholipid syndrome (APS) refers to persistent antiphospholipid antibodies (aPL)
associated with thrombotic and/or obstetrical complications. The endothelial cell is a target …

Despite the widely recognized practical importance of anticardiolipin (aCL) ELISA, the
reliability of this test has been recently discussed. In order to investigate this area on European …

Various antiphospholipid and/or antiprotein antibodies have been suspected to be associated
with recurrent early foetal loss in absence of any habitual aetiology. We conducted a …

Antiphospholipid ELISAs are part of the Antiphospholipid Antibodies Syndrome classification
criteria, having the same diagnostic value as lupus anticoagulant. However, sometimes …

OBJECTIVE: To assess the frequency of epilepsy in primary and secondary antiphospholipid
syndrome (APS); to analyze the clinical and laboratory features characterizing those with …

Pemphigus and bullous pemphigoid are two autoimmune diseases that have a similar
pathogenesis. Both have a genetic predisposition which promotes the production of auto-…

A multicenter study was set up to evaluate the prevalence, clinical and biological significance
of antiphosphatidylethanolamine antibodies (aPE) in thrombotic patients with or without …

Inter-laboratory variability of anti-β 2 -glycoprotein I antibody measurements (IgG and IgM)
was investigated in the frame of the European Forum on Antiphospholipid Antibodies and its …